1 week Ago By ABMN Staff
Parkside Financial Bank & Trust boosted its stake in shares of Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ) by 9.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 8,684 shares of the company’s stock after acquiring an additional 771 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Privia Health Group were worth $151,000 as of its most recent SEC filing. Other hedge funds and other institutional investors also recently made changes to their positions in the company.
Nisa Investment Advisors LLC grew its holdings in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after purchasing an additional 930 shares during the last quarter.
Signaturefd LLC grew its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after buying an additional 626 shares during the last quarter.
Park Place Capital Corp increased its holdings in shares of Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after buying an additional 1,335 shares in the last quarter.
Covestor Ltd raised its stake in shares of Privia Health Group by 25.5% in the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock valued at $104,000 after acquiring an additional 1,076 shares during the last quarter.
Finally, SG Americas Securities LLC acquired a new position in shares of Privia Health Group in the 1st quarter worth approximately $131,000. 94.48% of the stock is owned by institutional investors.
Analyst Ratings Changes PRVA has been the subject of a number of recent analyst reports. Barclays dropped their price target on Privia Health Group from $22.00 to $19.
00 and set an “equal weight” rating for the company in a report on Monday, May 20th. Truist Financial cut their price target on Privia Health Group from $28.00 to $24.
00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Robert W. Baird increased their price objective on shares of Privia Health Group from $23.
00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Evercore ISI dropped their target price on shares of Privia Health Group from $23.
00 to $20.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Finally, Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th.
Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $24.86.
Privia Health Group Stock Down 1.7 % PRVA stock opened at $18.66 on Friday.
Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.
11. The company has a market cap of $2.23 billion, a P/E ratio of 124.
40, a price-to-earnings-growth ratio of 4.70 and a beta of 0.77.
The business’s fifty day moving average is $19.23 and its 200-day moving average is $18.84.
Privia Health Group ( NASDAQ:PRVA – Get Free Report ) last released its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.
05 by ($0.02). Privia Health Group had a net margin of 0.
88% and a return on equity of 2.42%. The company had revenue of $422.
30 million during the quarter, compared to analyst estimates of $411.50 million. During the same period in the previous year, the company posted $0.
06 EPS. The company’s quarterly revenue was up 2.2% compared to the same quarter last year.
Research analysts anticipate that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.
Privia Health Group Company Profile ( Free Report ) Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. Read More Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ). Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.
com's FREE daily email newsletter ..
